Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Protara Therapeutics (TARA) EBIT: 2013-2014

Historic EBIT for Protara Therapeutics (TARA) over the last 2 years, with Dec 2014 value amounting to -$7.6 million.

  • Protara Therapeutics' EBIT was N/A to -$3.3 million in Q4 2014 from the same period last year, while for Dec 2014 it was -$7.6 million, marking a year-over-year change of. This contributed to the annual value of -$7.6 million for FY2014, which is 6.43% down from last year.
  • According to the latest figures from FY2014, Protara Therapeutics' EBIT is -$7.6 million, which was down 6.43% from -$7.1 million recorded in FY2013.
  • Protara Therapeutics' EBIT's 5-year high stood at -$7.1 million during FY2013, with a 5-year trough of -$7.6 million in FY2014.
  • Over the past 2 years, Protara Therapeutics' median EBIT value was -$7.4 million (recorded in 2013), while the average stood at -$7.4 million.
  • Data for Protara Therapeutics' EBIT shows a maximum YoY decreased of 6.43% (in 2014) over the last 5 years.
  • Yearly analysis of 2 years shows Protara Therapeutics' EBIT stood at -$7.1 million in 2013, then decreased by 6.43% to -$7.6 million in 2014.